Anti-Ro52 has been shown to be involved in the mechanisms of many rheumatic diseases, including SLE, systemic sclerosis, inflammatory myositis and juvenile idiopathic arthritis (21, 22). This evidence concerns the gene TRIM21 and juvenile idiopathic arthritis.